Role of Amlodipine in Reduction of CIN
ConditionContrast-induced Nephropathy
Trial statusNot yet recruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-70
SponsorMinia University
About this trial
The aim is to assess the benefit of low dose oral amlodipine in renal protection from contrast induced nephropathy in diabetic patients in intensive care unit
Eligibility criteria
Qualifiers
adult patients of both sexes (18:70) diabetic patients with serum creatinine below 1.2 hemodynamically stable patients ASA physical status 2,3
Disqualifiers
patient refusal patients of chronic kidney diseases NPO patients serum creatinine above 1.2 Hypertensive patients
Trial design
Treatments tested in this trial
- Calcium channel blocker
- Hydration
Treatment groups
40 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov